Projects / Strategies for the next years

It was decided to initially focus on thyroid and adrenal glands, and the key investigators from both disease areas are equally represented in the EnTF.

The EnTF strategy will focus on:

  1. Pan European studies
    To be successful in these rare tumors, sufficient numbers of patients need to be enrolled into clinical trials. Many trials in these diseases have been discontinued due to poor enrollment. The goal of the EORTC is to simplify, streamline and harmonize clinical trials in these diseases accross Europe.
  2. Translational research
    Translational research is important for better identification of predictive and prognostic factors as well as to identify patient populations most likely to benefit. The EORTC, with its strong focus and background in translational research and bio banking, will be able to foster and maintain robust translational research projects.
  3. Collaboration with national and international groups
    In line with its long term strategy, the EORTC has developed an excellent track record of transcontinental intergroup collaboration. EORTC Headquarters expertise in the field of legal and regulatory issues is highly respected, and this is of signicant value in terms of conducting efficient international collaboration.